Barclays’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-105
| Closed | -$1K | – | 4371 |
|
|
2023
Q4 | $1K | Buy |
+105
| New | +$1K | ﹤0.01% | 4185 |
|
|
2023
Q3 | – | Sell |
-3,379
| Closed | -$23K | – | 4466 |
|
|
2023
Q2 | $23K | Buy |
3,379
+2,703
| +400% | +$18.4K | ﹤0.01% | 3949 |
|
|
2023
Q1 | $5K | Buy |
676
+60
| +10% | +$444 | ﹤0.01% | 4164 |
|
|
2022
Q4 | $4K | Sell |
616
-827
| -57% | -$5.37K | ﹤0.01% | 4245 |
|
|
2022
Q3 | $14K | Hold |
1,443
| – | – | ﹤0.01% | 4069 |
|
|
2022
Q2 | $28K | Sell |
1,443
-304
| -17% | -$5.9K | ﹤0.01% | 3972 |
|
|
2022
Q1 | $88K | Sell |
1,747
-1,966
| -53% | -$99K | ﹤0.01% | 3736 |
|
|
2021
Q4 | $281K | Buy |
3,713
+596
| +19% | +$45.1K | ﹤0.01% | 2734 |
|
|
2021
Q3 | $246K | Sell |
3,117
-494
| -14% | -$39K | ﹤0.01% | 2891 |
|
|
2021
Q2 | $500K | Buy |
3,611
+1,902
| +111% | +$263K | ﹤0.01% | 2473 |
|
|
2021
Q1 | $358K | Buy |
1,709
+37
| +2% | +$7.75K | ﹤0.01% | 2846 |
|
|
2020
Q4 | $277K | Buy |
1,672
+190
| +13% | +$31.5K | ﹤0.01% | 2569 |
|
|
2020
Q3 | $252K | Sell |
1,482
-828
| -36% | -$141K | ﹤0.01% | 2621 |
|
|
2020
Q2 | $383K | Buy |
2,310
+889
| +63% | +$147K | ﹤0.01% | 2479 |
|
|
2020
Q1 | $164K | Buy |
1,421
+199
| +16% | +$23K | ﹤0.01% | 2629 |
|
|
2019
Q4 | $180K | Buy |
1,222
+569
| +87% | +$83.8K | ﹤0.01% | 3227 |
|
|
2019
Q3 | $89K | Buy |
653
+271
| +71% | +$36.9K | ﹤0.01% | 3460 |
|
|
2019
Q2 | $50K | Buy |
382
+306
| +403% | +$40.1K | ﹤0.01% | 3832 |
|
|
2019
Q1 | $7K | Buy |
+76
| New | +$7K | ﹤0.01% | 4047 |
|